BioPlus Acquisition Corp.

BIOS · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2018
12/31/2017
Assets
Cash & Equivalents$140$636$14,500$39,500
Short-Term Investments$0$0$0$0
Receivables$0$0$114,900$85,500
Inventory$0$0$26,700$38,000
Other Curr. Assets$408$367$18,600$24,700
Total Curr. Assets$549$1,002$174,700$187,700
Property Plant & Equip (Net)$0$0$28,800$27,000
Goodwill$0$0$367,200$367,200
Intangibles$0$0$10,500$19,100
Long-Term Investments$237,776$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$234,979$2,700$2,100
Total NC Assets$237,776$234,979$409,200$415,400
Other Assets$0$0$0$0
Total Assets$238,325$235,981$583,900$603,100
Liabilities
Payables$0$0$67,000$66,000
Short-Term Debt$0$0$0$0
Tax Payable$0$0$1,000$1,014
Deferred Revenue$408$0$0$0
Other Curr. Liab.$527$179$40,300$39,100
Total Curr. Liab.$527$179$107,300$105,100
LT Debt$5,000$5,000$501,500$478,900
Deferred Rev, NC$0$0-$435,532$0
Deferred Tax Liab, NC$0$0$1,032$0
Other NC Liab.$9,800$9,800$460,400$21,800
Total NC Liab.$14,800$14,800$527,400$500,700
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$15,327$14,979$634,700$605,800
Equity
Pref Stock$0$0$0$0
Common Stock$237,776$234,601$0$0
Retained Earnings-$14,779-$13,599-$761,200-$709,500
AOCI$0$0-$100,900-$88,300
Other Equity$0$0$811,400$795,100
Total Equity$222,998$221,002-$50,700-$2,700
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$238,325$235,981$584,000$603,100
Net Debt$4,860$4,364$487,000$439,400